StockData
Ensysce Biosciences, Inc. logo

Ensysce Biosciences, Inc. (ENSC) stock

ENSCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$0.38−0.03 (-6.28%)

Close on Nov 17, 2026Market cap $7.47MP/E –Yield –

Ensysce Biosciences price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Ensysce Biosciences's price to sales ratio was 1.3× on Nov 11, 2026, against 1.3× a year earlier. Over the last 5 years it ranged from 0.3× to 377.6×, with a median of 1.3×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.3×+0.6
2025Dec 31, 20250.7×−1.1
2024Dec 31, 20241.7×+0.7
2023Dec 29, 20231.0×−6.3
2022Dec 30, 20227.3×−77.4
2021Oct 29, 202184.7×–

More Ensysce Biosciences figures

See a number that looks wrong?